Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
New York Proton Center · University School · +1 more institution
Abstract
Established tumors are typified by an immunosuppresive microenvironment. Countering this naturally occurring phenomenon, emerging evidence suggests that radiation promotes a proimmunogenic milieu within the tumor capable of stimulating host cancer-specific immune responses. Three cryptic immunogenic components of cytotoxic-agent induced cell death-namely, calreticulin cell surface exposure, the release of high mobility group box 1 (HMGB1) protein, and the liberation of ATP-have been previously shown to be critical for dendritic cell (DC) activation and effector T-cell priming. Thus, these immune-mobilizing components commonly presage tumor rejection in response to treatment. We initially set out to address the…
Citation impact
- FWCI
- 15.51
- Percentile
- 100%
- References
- 37
Authors
6- EBEncouse B. Golden
New York Proton Center, University School, New York University
- DFDerek Frances
New York Proton Center, University School, New York University
- IPIlenia Pellicciotta
New York Proton Center, University School, New York University
- SDSandra Demaria
New York Proton Center, University School, New York University
- MHMary Helen Barcellos‐Hoff
New York Proton Center, University School, New York University
Topics & keywords
- Immunogenic cell death
- Medicine
- Radiation therapy
- Cancer research
- Calreticulin
- Immune system
- Carboplatin
- Programmed cell death
- Good health and well-being